/Edwards%20Lifesciences%20Corp%20logo%20on%20phone-%20by%20IgorGolovniov%20via%20Shutterstock.jpg)
With a market cap of $40.7 billion, Edwards Lifesciences Corporation (EW) provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. Founded in 1958, the Irvine, California-based company distributes its products through a direct sales force and independent distributors.
Companies valued at more than $10 billion or more are generally considered “large-cap stocks”, and EW fits this criterion perfectly.